Elisabeth Kjellén

Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial

Anders Widmark, Adalsteinn Gunnlaugsson, L. Beckman et al. · The Lancet · 2019 · 840 citations

Surgical Oncology, Radiation Therapy, Medicine +8

FDG PET studies during treatment: Prediction of therapy outcome in head and neck squamous cell carcinoma

Eva Brun, Elisabeth Kjellén, Jan Tennvall et al. · Head & Neck · 2002 · 250 citations

Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC): patient-reported quality-of-life outcomes of a randomised, controlled, non-inferiority, phase 3 trial

Per Fransson, Per Nilsson, Adalsteinn Gunnlaugsson et al. · The Lancet Oncology · 2021 · 151 citations

Radiation Medicine, Radiation Therapy, Medicine +8

Tumor angiogenesis and prognosis in squamous cell carcinoma of the head and neck

Ulf K. Zätterström, Eva Brun, Roger Wïllén et al. · Head & Neck · 1995 · 128 citations

Chromosomal abnormalities involving 11q13 are associated with poor prognosis in patients with squamous cell carcinoma of the head and neck

Jan Åkervall, Yuesheng Jin, Johan Wennerberg et al. · Cancer · 1995 · 119 citations